The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Abstract
PURPOSE: To review the clinical, epidemiologic, immunologic, and virologic aspects of the chronic myelopathy associated with human T-cell leukemia/lymphoma virus type I (HTLV-I), currently called tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). DATA IDENTIFICATION: Studies done after 1985, when TSP/HAM was first recognized, were identified by a computer search using MEDLARS II and CANCERLIT. Additional information was acquired from personal files and bibliographies of existing literature. STUDY SELECTION: A total of 400 articles, 90 book chapters, and 150 abstracts from meetings covering all aspects of HTLV-I and neurologic diseases were critically analyzed, and information from 250 publications was included. RESULTS OF DATA ANALYSIS: TSP/HAM is present in most HTLV-I endemic areas, with a prevalence ranging from 5.1 to 128 per 100,000 inhabitants. Up to 20% of patients develop TSP/HAM after transfusion of HTLV-I contaminated blood. Pathologic characteristics indicate a chronic meningomyelitis. The clinical features consist of a chronic progressive spastic paraparesis or paraplegia, sphincter disturbances, and minimal sensory loss. Supraspinal and peripheral nerve involvement is sometimes observed. High titers of HTLV-I-specific antibodies are present in the serum and cerebrospinal fluid. The high level of humoral and cellular immunologic response and the association of TSP/HAM with other immunologic diseases suggest an immune-mediated process. Corticosteroids and immunosuppressor treatment usually result in only short-term improvement. CONCLUSION: TSP/HAM is a common neurologic disease in many parts of the world. All patients with chronic progressive myelopathies should be tested for serum and cerebrospinal fluid HTLV-I-specific antibodies. Systematic screening of blood donors for HTLV-I is necessary to help prevent the dissemination of the virus and the occurrence of post-transfusional cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seiki, M., Hattori, S., Hirayama, Y., & Yoshida, M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3618 · Cited by 1,525
Human T-Lymphotropic Virus Type I (HTLV-I) Seroprevalence in Jamaica
Murphy, E., Figueroa, P., Gibbs, W. N., Holding-Cobham, M., Cranston, B., Malley, K., Bodner, A. J., Alexander, S. S., & Blattner, W. A. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115824 · Cited by 199
Kira, J., Koyanagi, Y., Yamada, T., Itoyama, Y., Goto, I., Yamamoto, N., Sasaki, H., & Sakaki, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410290214 · Cited by 152
Gessain, A., Saal, F., Gout, O., Daniel, M., Flandrin, G., de The, G., Peries, J., & Sigaux, F. (1990) · Blood · doi:10.1182/blood.v75.2.428.428 · Cited by 130
Self-citationKira, J.-I., Fujihara, K., Itoyama, Y., Goto, I., & Hasuo, K. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90192-a · Cited by 96
Cited by
Jeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3848 · Cited by 419
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
Franchini, G. (1995) · Blood · doi:10.1182/blood.v86.10.3619.bloodjournal86103619 · Cited by 360
Nakagawa, M., Izumo, S., Ijichi, S., Kubota, H., Arimura, K., Kawabata, M., & Osame, M. (1995) · Journal of Neurovirology · doi:10.3109/13550289509111010 · Cited by 316
An HTLV-I Vaccine: Why, How, for Whom?
DE THÉ, G., & BOMFORD, R. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.381 · Cited by 272
Castro-Costa, C. M. D., Araújo, A. Q. C., Barreto, M. M., Takayanagui, O. M., Sohler, M. P., Silva, E. L. M. D., Paula, S. M. B. D., Ishak, R., Ribas, J. G. R., Rovirosa, L. C., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.931 · Cited by 266
Metadata
- Authors
- Gessain, A., & Gout, O.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1992-12-01
- Volume
- 117
- Issue
- 11
- Pages
- 933-946
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2010710421
- Cited by
- 205
- References
- 5
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I). https://app.cochat.ai/papers/10.7326/0003-4819-117-11-933
- The paper
- Gessain, A., & Gout, O. (1992). Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-117-11-933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.